Max W Sung - Internal Medicine | Mount Sinai

About Me

Max Sung, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. He has been on the faculty at Mount Sinai since 1987.

Dr. Sung specializes in gastrointestinal cancers including liver, bile duct, pancreas, esophagus, stomach, colon/rectum, and anus cancers. His approach to cancer treatment is multi-disciplinary, and involves collaboration with other specialties such as surgery, interventional radiology, and radiation therapy.

Dr. Sung has held numerous leadership roles at Mount Sinai, including Medical Director of The Ruttenberg Treatment Center and Chair of the Data and Safety Monitoring Committee for cancer clinical trials.

Dr. Sung is involved in clinical cancer research and has authored numerous peer-reviewed publications on innovative and translational treatments.

Dr. Sung is fluent in English and Chinese (Cantonese and Mandarin), and has a working knowledge of German and French.

Language

Chinese (Mandarin), English, Chinese (Cantonese)

Position

PROFESSOR | Medicine, Hematology and Medical Oncology

Hospital Affiliations

Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Brooklyn
Mount Sinai Queens
The Mount Sinai Hospital
Mount Sinai West

Clinical Focus

Education

MD, Albert Einstein College of Medicine

Internship, Internal Medicine

Montefiore Medical Center

Residency, Internal Medicine

Montefiore Medical Center

Fellowship, Hematology

Montefiore Medical Center

Certifications

American Board of Internal Medicine

Research

Dr. Sung is currently conducting clinical trials of immunotherapy in patients with advanced colorectal and breast cancers using gene transfer therapy. He is also involved in clinical trials of suicide gene therapy and differentiation therapies for colorectal cancer, and anti-angiogenesis therapy for hepatocellular carcinoma.

Dr. Sung actively participates in multi-modality treatment approaches (surgery/radiation/chemotherapy) to cancers of the liver, colon-rectum, carcinoid, pancreas, esophagus, stomach and anal cancers, and is also experienced in regional treatment modalities such as hepatic arterial chemotherapy/chemoembolization and intraperitoneal chemotherapy.

Locations

Ruttenberg Treatment Center

1470 Madison Avenue, 3rd Floor, New York, NY, 10029

212-241-6756

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Patients with Healthfirst Medicare Advantage insurance: Effective 9/1/2024, Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.

Ruttenberg Treatment Center1470 Madison Avenue, 3rd Floor, New York, NY, 10029

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Publications:62

Selected Publications

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Sung during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

AstraZeneca AB

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Max W Sung, MD

Internal Medicine, Cancer (Oncology), Hematology-Oncology

About Me

Language

Position

Hospital Affiliations

About Me

Language

Position

Hospital Affiliations

Clinical Focus

Education

MD, Albert Einstein College of Medicine

Internship, Internal Medicine

Residency, Internal Medicine

Fellowship, Hematology

Certifications

American Board of Internal Medicine

Research

Locations

Ruttenberg Treatment Center

Insurance Information

Publications

Selected Publications

Industry Relationships